New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainNew findings from researchers in the Perelman School of Medicine at the University of Pennsy
Oncology June 01,2024
Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainNew findings from researchers in the Perelman School of Medicine at the University of Pennsy
Oncology June 01,2024
Researchers block two cancer cell signaling pathways and slow tumor growth

Researchers block two cancer cell signaling pathways and slow tumor growth

by Case Western Reserve UniversityBlocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in t
Oncology June 01,2024
Researchers block two cancer cell signaling pathways and slow tumor growth

Researchers block two cancer cell signaling pathways and slow tumor growth

by Case Western Reserve UniversityBlocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in t
Oncology June 01,2024
Study suggests new strategies against bone metastases from prostate cancer

Study suggests new strategies against bone metastases from prostate cancer

by Garth Sundem,CU Anschutz Medical CampusWhen prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 pe
Oncology June 01,2024
Study suggests new strategies against bone metastases from prostate cancer

Study suggests new strategies against bone metastases from prostate cancer

by Garth Sundem,CU Anschutz Medical CampusWhen prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 pe
Oncology June 01,2024
Study explores new tracer in prostate cancer hunt

Study explores new tracer in prostate cancer hunt

by Paul Mayne,University of Western OntarioWestern Oncology professor Glenn Bauman leads a multi-centre trial registry testing the use of a new imaging tracer for more precise detection and trea
Oncology June 01,2024
Study explores new tracer in prostate cancer hunt

Study explores new tracer in prostate cancer hunt

by Paul Mayne,University of Western OntarioWestern Oncology professor Glenn Bauman leads a multi-centre trial registry testing the use of a new imaging tracer for more precise detection and trea
Oncology June 01,2024
Researchers find key to help treat different cancers

Researchers find key to help treat different cancers

by Yale UniversityYale Cancer Center (YCC) scientists have uncovered the workings of a metabolic pathway or "gauge" that lets cancer cells detect when they have enough nutrients around
Oncology June 01,2024
Researchers find key to help treat different cancers

Researchers find key to help treat different cancers

by Yale UniversityYale Cancer Center (YCC) scientists have uncovered the workings of a metabolic pathway or "gauge" that lets cancer cells detect when they have enough nutrients around
Oncology June 01,2024
Study hints at why an aggressive form of brain cancer is hard to treat

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills
Oncology June 01,2024
Study hints at why an aggressive form of brain cancer is hard to treat

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills
Oncology June 01,2024
Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

by Katie Neith,City of Hope National Medical CenterCredit: Unsplash/CC0 Public DomainIn a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology,
Oncology June 01,2024
Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

by Katie Neith,City of Hope National Medical CenterCredit: Unsplash/CC0 Public DomainIn a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology,
Oncology June 01,2024
Researchers trace timeline of tumor evolution in metastatic breast cancer patients

Researchers trace timeline of tumor evolution in metastatic breast cancer patients

by University of Utah Health SciencesTheresa Werner, MD, Medical Director of the Clinical Trials Office at Huntsman Cancer Institute and Associate Professor of Medicine at the University of Utah.
Oncology June 01,2024
Researchers trace timeline of tumor evolution in metastatic breast cancer patients

Researchers trace timeline of tumor evolution in metastatic breast cancer patients

by University of Utah Health SciencesTheresa Werner, MD, Medical Director of the Clinical Trials Office at Huntsman Cancer Institute and Associate Professor of Medicine at the University of Utah.
Oncology June 01,2024
Research: Subset of breast cancers have two PIK3CA mutations on the same allele

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat
Oncology June 01,2024
Research: Subset of breast cancers have two PIK3CA mutations on the same allele

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat
Oncology June 01,2024
Researchers block metastasis-promoting enzyme, halt spread of breast cancer

Researchers block metastasis-promoting enzyme, halt spread of breast cancer

by University of California, San FranciscoCredit: CC0 Public DomainIn a breakthrough with important implications for the future of immunotherapy for breast cancer, UC San Francisco scientists hav
Oncology June 01,2024
Researchers block metastasis-promoting enzyme, halt spread of breast cancer

Researchers block metastasis-promoting enzyme, halt spread of breast cancer

by University of California, San FranciscoCredit: CC0 Public DomainIn a breakthrough with important implications for the future of immunotherapy for breast cancer, UC San Francisco scientists hav
Oncology June 01,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com